Skip to main content

Table 4 Survival on breast IMPC and IDC in previous seven reports and the present study

From: Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma

Author Median follow-up (month) OS (IMPC vs IDC) FFS (IMPC vs IDC) LRFS (IMPC vs IDC) DMFS (IMPC vs IDC)
Chen [4] 60.1 59 vs 77 %
P = 0.004
/ 88.8 vs 96 %
P = 0.055
61.2 vs 72 %
P = 0.108
Yu [8] 45.0 86 vs 87.7 %
P = 0.18
/ 68.2 vs 81.4 %
P = 0.045
78.1 vs 79.3 %
P = 0.86
Vingiani [14] 51.0 89.8 vs 90.8 %
P = 0.8
75.5 vs 79.6 %
P = 0.47
/ /
Liu [9] 68.4 / 84.3 vs 78.4 %
P = 0.518
/ /
Shi [7] 40.5 75.9 vs 89.5 %
P = 0.001
67.1 vs 84.5 %
P < 0.001
/ /
Chen [10] 48.0 82.9 vs 80.5 %
P = 0.52
/ / /
Yu [16] 59.0 97.7 vs 95.7 %
P = 0.67
/ 91.8 vs 96.3 %
P = 0.03
/
Present study 39.0 97 vs 94.2 %
P = 0.78
87.9 vs 86.2 %
P = 0.91
93.9 vs 89.0 %
P = 0.82
90.9 vs 89 %
P = 0.97
  1. IMPC invasive micropapillary carcinoma, IDC invasive ductal carcinoma, OS overall survival, LRFS local relapse-free survival, DMFS distant metastasis-free survival, FFS failure-free survival